| Product NDC: | 59702-800 |
| Proprietary Name: | Atuss DS Tannate Suspension |
| Non Proprietary Name: | Tannate Suspension |
| Active Ingredient(s): | 4; 30; 30 mg/5mL; mg/5mL; mg/5mL & nbsp; Tannate Suspension |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59702-800 |
| Labeler Name: | Atley Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20061121 |
| Package NDC: | 59702-800-15 |
| Package Description: | 15 mL in 1 BOTTLE (59702-800-15) |
| NDC Code | 59702-800-15 |
| Proprietary Name | Atuss DS Tannate Suspension |
| Package Description | 15 mL in 1 BOTTLE (59702-800-15) |
| Product NDC | 59702-800 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tannate Suspension |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20061121 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Atley Pharmaceuticals, Inc. |
| Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 4; 30; 30 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes | Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |